Skip to Content

Gilotrif

In the US, Gilotrif (afatinib systemic) is a member of the drug class multikinase inhibitors and is used to treat Non-Small Cell Lung Cancer.

US matches:

Ingredient matches for Gilotrif

Afatinib

Afatinib dimaleate (a derivative of Afatinib) is reported as an ingredient of Gilotrif in the following countries:

  • United States

← International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide